ziprasidone has been researched along with Anxiety Neuroses in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hetrick, SE; Loy, JH; Merry, SN; Stasiak, K | 1 |
| Cosgrove, VE; Feldman, NS; Gwizdowski, IS; Hidalgo, RB; McElroy, SL; Sheehan, DV; Suppes, T | 1 |
| Baer, L; Clain, A; Doorley, J; Fava, M; Heo, JY; Jeon, HJ; Mischoulon, D; Papakostas, GI; Pisoni, A | 1 |
| Connolly, JG; Schneeweiss, MC; Toomey, TJ | 1 |
| Alipour, A; Cruz, R; Lott, RS | 1 |
| Etemad, B; Gallop, R; Lohoff, FW; Mandos, LA; Rickels, K | 1 |
| Jackson, CW; Lorenz, RA; Saitz, M | 1 |
| Maharaj, K; Privitera, MR | 1 |
| Crane, DL | 1 |
| Rickels, K; Rynn, MA; Snyderman, SH | 1 |
| Anders, JL | 1 |
2 review(s) available for ziprasidone and Anxiety Neuroses
| Article | Year |
|---|---|
Atypical antipsychotics for disruptive behaviour disorders in children and youths.
Topics: Adolescent; Aggression; Antipsychotic Agents; Anxiety Disorders; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Conduct Disorder; Depressive Disorder, Major; Dibenzothiazepines; Humans; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Thiazoles; Weight Gain | 2017 |
Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder.
Topics: Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Dibenzothiazepines; Drug Resistance; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Thiazoles | 2010 |
4 trial(s) available for ziprasidone and Anxiety Neuroses
| Article | Year |
|---|---|
A randomized, double-blind, placebo-controlled study of ziprasidone monotherapy in bipolar disorder with co-occurring lifetime panic or generalized anxiety disorder.
Topics: Adult; Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Comorbidity; Double-Blind Method; Humans; Middle Aged; Panic Disorder; Piperazines; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Thiazoles; Treatment Outcome; Young Adult | 2014 |
Efficacy of ziprasidone monotherapy in patients with anxious depression: a 12-week, randomized, double-blind, placebo-controlled, sequential-parallel comparison trial.
Topics: Adult; Antidepressive Agents; Anxiety Disorders; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Thiazoles; Treatment Outcome | 2015 |
Ziprasidone treatment of refractory generalized anxiety disorder: a placebo-controlled, double-blind study.
Topics: Adult; Anxiety Disorders; Dizziness; Double-Blind Method; Female; Humans; Male; Pilot Projects; Piperazines; Sleep Stages; Thiazoles; Treatment Outcome | 2010 |
Open-label pilot study of ziprasidone for refractory generalized anxiety disorder.
Topics: Adult; Aged; Antipsychotic Agents; Anxiety Disorders; Drug Resistance; Female; Humans; Male; Middle Aged; Pilot Projects; Piperazines; Psychiatric Status Rating Scales; Thiazoles | 2005 |
5 other study(ies) available for ziprasidone and Anxiety Neuroses
| Article | Year |
|---|---|
Metabolic monitoring for youths initiating use of second-generation antipsychotics, 2003-2011.
Topics: Adolescent; Affective Disorders, Psychotic; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Blood Glucose; Child; Child, Preschool; Cohort Studies; Conduct Disorder; Databases, Factual; Depressive Disorder; Diabetes Mellitus; Female; Glycated Hemoglobin; Guideline Adherence; Humans; Hyperkinesis; Male; Mass Screening; Mental Disorders; Olanzapine; Piperazines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone; Thiazoles | 2015 |
Torsade de pointes after ziprasidone overdose with coingestants.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Drug Overdose; Female; Humans; Long QT Syndrome; Middle Aged; Piperazines; Thiazoles; Torsades de Pointes | 2010 |
Mania from dose-related ziprasidone augmentation of an SSRI.
Topics: Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Piperazines; Selective Serotonin Reuptake Inhibitors; Thiazoles | 2003 |
Ziprasidone as an augmenting agent in the treatment of anxiety-spectrum disorders.
Topics: Adult; Antipsychotic Agents; Anxiety Disorders; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Panic Disorder; Piperazines; Selective Serotonin Reuptake Inhibitors; Thiazoles; Treatment Outcome | 2005 |
Applying parsimony to "An African patient with ziprasidone intolerance".
Topics: Antipsychotic Agents; Anxiety Disorders; Black or African American; Culture; Depressive Disorder; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Pharmacogenetics; Piperazines; Polymorphism, Genetic; Thiazoles | 2005 |